NCT03634696 is a NA clinical trial of mPCL in Cancer, sponsored by Susan Miesfeldt.

Who is sponsoring NCT03634696?

NCT03634696 is sponsored by Susan Miesfeldt.

What drugs are being tested in NCT03634696?

Interventions in NCT03634696: mPCL, Usual Care.

Is NCT03634696 still recruiting?

NCT03634696 is currently completed. Last updated 14 October 2021.

Last reviewed 2021-10-14 · How we verify

NCT03634696

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

m-Palliative Care Link: Improving Palliative Care for Late Stage Tanzanian Cancer Patients

Completed NA Last updated 14 October 2021

What this trial tests

NA trial testing mPCL in Cancer in 98 participants. Completed in 20 July 2021.

Timeline

15 June 2018

Primary endpoint
9 August 2019

20 July 2021

Quick facts

Lead sponsor	Susan Miesfeldt
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	98
Start date	15 June 2018
Primary completion	9 August 2019
Estimated completion	20 July 2021
Sites	1 location across Tanzania

Drugs / interventions tested

mPCL
Usual Care

Conditions studied

Cancer — all drugs for Cancer →

Sponsor

Susan Miesfeldt

Who can join

21 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This work aims to improve late-stage cancer patients' access to high quality, patient-centered symptom assessment and control via the creation, field test, and outcomes assessment of a scalable mobile application (mPalliative Care Link; mPCL)-built around a locally-validated Palliative care Outcome Scale- that links a limited pool of existing Tanzanian palliative care specialists with patients, lay/family caregivers, and local health workers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03634696 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Susan Miesfeldt
Last refreshed: 14 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03634696.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing